title: IgA monoclonal gammopathy accompanying extranodal B cell lymphomas.
authors.affiliation: Department of Hematology, Zhongshan Hospital Fudan University, 180 Fenglin Road, Shanghai, 200032, China.
authors.forename: Boting
authors.initials: B
authors.lastname: Wu
authors.forename: Pu
authors.initials: P
authors.lastname: Chen
authors.forename: Weiguang
authors.initials: W
authors.lastname: Wang
authors.forename: Feng
authors.initials: F
authors.lastname: Li
authors.forename: Shanhua
authors.initials: S
authors.lastname: Zou
authors.forename: Yunfeng
authors.initials: Y
authors.lastname: Cheng
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005770:Gastrointestinal Neoplasms / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D006689:Hodgkin Disease / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis*; D007145:Immunoglobulin kappa-Chains / Q000032:analysis; D007146:Immunoglobulin lambda-Chains / Q000032:analysis; D008175:Lung Neoplasms / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D018442:Lymphoma, B-Cell, Marginal Zone / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D008224:Lymphoma, Follicular / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010265:Paraproteinemias / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D011241:Prednisone / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D012008:Recurrence; D012074:Remission Induction; D000069283:Rituximab; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007070:Immunoglobulin A; D007145:Immunoglobulin kappa-Chains; D007146:Immunoglobulin lambda-Chains; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone